These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 3519238

  • 21. Effects of furosemide, captopril and indometacin on the renin-angiotensin system and the renal prostaglandins in anesthetized neonatal piglets.
    Joppich R, Weyer P, Eife R.
    Arzneimittelforschung; 1995 Jul; 45(7):822-5. PubMed ID: 8573231
    [Abstract] [Full Text] [Related]

  • 22. Failure of angiotensin II to suppress plasma renin activity in normotensive subjects with a positive family history of hypertension.
    Herlitz H, Palmgren E, Widgren B, Aurell M.
    Clin Sci (Lond); 2005 Sep; 109(3):311-7. PubMed ID: 15901242
    [Abstract] [Full Text] [Related]

  • 23. Converting enzyme inhibition in mild and moderate essential hypertension. II.
    Rasmussen S, Leth A, Ibsen H, Damkjaer Nielsen M, Nielsen F, Giese J.
    Acta Med Scand; 1986 Sep; 219(1):29-36. PubMed ID: 3006449
    [Abstract] [Full Text] [Related]

  • 24. Plasma vasopressin as influenced by acute and chronic blockade of the renin-angiotensin system.
    Stanek B, Bruckner U, Silberbauer K.
    J Hypertens Suppl; 1985 Nov; 3(2):S129-31. PubMed ID: 3003301
    [Abstract] [Full Text] [Related]

  • 25. Hyperglycemia and angiotensin-mediated control of the renal circulation in healthy humans.
    Osei SY, Price DA, Fisher ND, Porter L, Laffel LM, Hollenberg NK.
    Hypertension; 1999 Jan; 33(1 Pt 2):559-64. PubMed ID: 9931165
    [Abstract] [Full Text] [Related]

  • 26. Renal characteristics and effect of angiotensin suppression in oral contraceptive users.
    Ribstein J, Halimi JM, du Cailar G, Mimran A.
    Hypertension; 1999 Jan; 33(1):90-5. PubMed ID: 9931087
    [Abstract] [Full Text] [Related]

  • 27. Effects of angiotensin and angiotensin blockade on coronary circulation and coronary reserve.
    Magrini F, Reggiani P, Roberts N, Meazza R, Ciulla M, Zanchetti A.
    Am J Med; 1988 Mar 11; 84(3A):55-60. PubMed ID: 3064599
    [Abstract] [Full Text] [Related]

  • 28. Renal adaptation to sodium deprivation. Effect of captopril in the rat.
    Mimran A, Jover B, Casellas D.
    Am J Med; 1984 May 31; 76(5B):14-21. PubMed ID: 6328982
    [Abstract] [Full Text] [Related]

  • 29. Effects of interrupting the renin-angiotensin system on sodium excretion in man.
    Brown J.
    J Physiol; 1988 Jan 31; 395():17-40. PubMed ID: 3045295
    [Abstract] [Full Text] [Related]

  • 30. Cyclosporin-induced renal vasoconstriction is augmented by frusemide and by angiotensin II in humans.
    Sturrock ND, Lang CC, Coutie WJ, Struthers AD.
    J Hypertens; 1995 Sep 31; 13(9):987-91. PubMed ID: 8586834
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Responses to converting enzyme and renin inhibition. Role of angiotensin II in humans.
    Fisher ND, Allan D, Kifor I, Gaboury CL, Williams GH, Moore TJ, Hollenberg NK.
    Hypertension; 1994 Jan 31; 23(1):44-51. PubMed ID: 8282330
    [Abstract] [Full Text] [Related]

  • 33. Effect of infused captopril on blood pressure and the renin-angiotensin-aldosterone system in normal dogs subjected to varying sodium balance.
    Morton JJ, Tree M, Casals-Stenzel J.
    Am J Cardiol; 1982 Apr 21; 49(6):1395-400. PubMed ID: 7041583
    [Abstract] [Full Text] [Related]

  • 34. Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure.
    Motwani JG, Fenwick MK, Morton JJ, Struthers AD.
    Circulation; 1992 Aug 21; 86(2):439-45. PubMed ID: 1638713
    [Abstract] [Full Text] [Related]

  • 35. Urinary excretion of aquaporin-2 after furosemide and felodipine in healthy humans.
    Starklint J, Bech JN, Pedersen EB.
    Scand J Clin Lab Invest; 2005 Aug 21; 65(3):249-61. PubMed ID: 16095054
    [Abstract] [Full Text] [Related]

  • 36. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
    Bech JN, Nielsen EH, Pedersen RS, Svendsen KB, Pedersen EB.
    Am J Hypertens; 2007 Mar 21; 20(3):287-95. PubMed ID: 17324742
    [Abstract] [Full Text] [Related]

  • 37. Influence of angiotensin II on pressure natriuresis and renal hemodynamics in volume-expanded rats.
    Mattson DL, Raff H, Roman RJ.
    Am J Physiol; 1991 Jun 21; 260(6 Pt 2):R1200-9. PubMed ID: 2058747
    [Abstract] [Full Text] [Related]

  • 38. Abnormal glomerular and tubular function during angiotensin converting enzyme inhibition in renovascular hypertension evaluated by the lithium clearance method.
    Pedersen EB, Sørensen SS, Amdisen A, Danielsen H, Eiskjaer H, Hansen HH, Jensen FT, Jespersen B, Madsen B, Nielsen HK.
    Eur J Clin Invest; 1989 Apr 21; 19(2):135-41. PubMed ID: 2499471
    [Abstract] [Full Text] [Related]

  • 39. Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-aldosterone system.
    Reams GP, Bauer JH, Gaddy P.
    Hypertension; 1986 Apr 21; 8(4):290-7. PubMed ID: 3007351
    [Abstract] [Full Text] [Related]

  • 40. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK, Larsen T, Vase H, Lauridsen TG, Jensen JM, Pedersen EB.
    Clin Exp Hypertens; 2013 Apr 21; 35(5):313-24. PubMed ID: 22966789
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.